eurotimes.org
latest issueLatest Issue
EUROTIMES 

Cheryl Guttman Krader

EuroTimes articles by Cheryl Guttman Krader

  • Adjustable Solutions for Pseudophakic Patients

    Sunday, May 1, 2022

    Add-on IOLs—a versatile choice for primary implantation or postsurgical enhancement. Cheryl Guttman Krader reports.

  • Is PKP a Timeless Procedure?

    Sunday, May 1, 2022

    Suggestions on choosing and improving outcomes of penetrating keratoplasty. Cheryl Guttman Krader reports.

  • Wireless Epiretinal Prosthesis for Patients with Retinal Degenerative Disease

    Friday, April 1, 2022

    Encouraging early outcomes in subjects with no or minimal light perception.

    Cheryl Guttman Krader reports.

  • One-Year Results for Juvene IOL

    Friday, April 1, 2022

    12-month data show refractive stability, promising functional outcomes.

    Cheryl Guttman Krader reports.

  • Remote Diabetic Retinopathy Screening: Ready for Prime Time?

    Friday, April 1, 2022

    Experts debate widespread implementation of telemedicine-based strategy. Cheryl Guttman Krader reports.

  • Advanced Retinal Implants

    Friday, April 1, 2022

    Early results promising for next-generation treatments.

    Cheryl Guttman Krader reports.

  • Corneal Disease Treatment Nothing but Magnetic

    Friday, April 1, 2022

    Positive results experienced with surgery that addresses underlying nerve loss.

    Cheryl Guttman Krader reports.

  • Real-World Experience with Anti-VEGF Injections during COVID-19

    Friday, April 1, 2022

    Differences in treatment patterns and outcomes offer insights for future care.

    Cheryl Guttman Krader reports.

  • Developing a Pan-Coronavirus Vaccine

    Friday, April 1, 2022

    Protection sought against SARS-CoV-2 variants and future coronavirus outbreaks. Cheryl Guttman Krader reports.

  • Adaptations for Low Vision

    Friday, April 1, 2022

    Improving quality of life and targeting challenges.

    Cheryl Guttman Krader reports.


Latest Articles


escrs members advert